LYCOS RETRIEVER
Provera: Contraceptives
built 608 days ago
Depo-Provera was approved for use as a contraceptive by Health Canada in April, 1997 after several previous applications by the manufacturer had been denied. Canada now joins over 90 other countries where Depo-Provera is approved, including the U.S.
Source:
, WHO concluded that, overall, women on Depo-Provera are not at increased risk of breast cancer. In addition, breast cancer risk did not increase the longer a woman stayed on the injectable contraceptive. The WHO position on Depo-Provera in 2007 remains that there is no evidence of a causation link between Depo-Provera and breast cancer.
Source:
Women can use Depo Provera discreetly. Since there are no pill packs or barrier methods to store, Depo Provera can be used covertly by women who wish not to disclose contraceptive use to family members or partners.
Source:
One in five black teenagers using birth control in the US uses Depo-Provera, a far higher rate of use than for white teenagers. Activists claim this is because black teenagers are disproportionately targeted for the least safe contraceptives.[63]
Source: